Lensar (LNSR) EBITDA Margin (2019 - 2026)
Lensar's (LNSR) quarterly EBITDA Margin came in at 16.67% in Q1 2026, up 5757.0% year-on-year from 0.28% in Q1 2025, and up 131.34% on a QoQ basis from 53.2% in Q4 2025.
Lensar (LNSR) EBITDA Margin (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of EBITDA Margin data on file, last reported at 16.67% in Q1 2026.
- On a quarterly basis, EBITDA Margin rose 5757.0% year-over-year to 16.67% in Q1 2026; TTM through Mar 2026 was 34.68%, a 501.0% decrease from a year earlier, with the FY2025 full-year figure at 47.58%, down 2438.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 16.67%, up from 53.2% in the prior quarter.
- Over the last five years, EBITDA Margin for LNSR reached as high as 16.67% in Q1 2026 and fell as low as 982.76% in Q1 2024.
- Historically, EBITDA Margin has averaged 96.21% across 5 years, with a median of 49.42% in 2024.
- Across the five-year window, EBITDA Margin plunged 92991 bps in 2024 and surged 94187 bps in 2025, its largest moves.
- Year by year, EBITDA Margin stood at 30.37% in 2022, then grew by 7 bps to 28.2% in 2023, then soared by 50 bps to 14.02% in 2024, then tumbled by 279 bps to 53.2% in 2025, then jumped by 131 bps to 16.67% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 16.67% in Q1 2026, 53.2% in Q4 2025, and 59.42% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | 16.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.67% |
| Dec 31, 2025 | -53.20% |
| Sep 30, 2025 | -59.42% |
| Jun 30, 2025 | -51.17% |
| Mar 31, 2025 | -40.89% |
| Dec 31, 2024 | -14.02% |
| Sep 30, 2024 | -10.54% |
| Jun 30, 2024 | -49.42% |
| Mar 31, 2024 | -982.76% |
| Dec 31, 2023 | -28.20% |
| Sep 30, 2023 | -24.66% |
| Jun 30, 2023 | -27.78% |
| Mar 31, 2023 | -52.85% |
| Dec 31, 2022 | -30.37% |
| Sep 30, 2022 | -52.70% |
| Jun 30, 2022 | -102.64% |
| Mar 31, 2022 | -71.55% |
| Dec 31, 2021 | -34.86% |
| Sep 30, 2021 | -88.24% |
| Jun 30, 2021 | -64.51% |